Semaglutide Ozempic / Wegovy
FDA Approved
The gentle starter Reduces appetite and slows digestion for steady weight loss. Highest lean mass loss ratio.
Weight Loss Ratio
60% fat 40% lean
Best For First-time GLP users Pure weight loss focus Patients with diabetic kidney disease risk Most extensive safety profile and dataTirzepatide Mounjaro / Zepbound
FDA Approved
The fast track Dual-action appetite and insulin control. Support stack recommended.
Weight Loss Ratio
67% fat 33% lean
Best For Patients wanting faster results Diabetic and pre-diabetic patients Moderate to obstructive sleep apnea Strongest FDA-approved optionRetatrutide Clinical Trials
Phase 3
The heavy hitter Triple agonist that increases metabolic rate with Glucagon action. Support stack required.
Weight Loss Ratio
70% fat 30% lean
Best For Maximum weight loss potential at rapid speed Metabolic reprogramming Patients with liver and visceral fat Patients willing to use support stacks